Aeglea BioTherapeutics (NASDAQ:AGLE) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a research report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a neutral rating and issued a $1.00 target price on shares of Aeglea BioTherapeutics in a report on Friday, March 3rd. […]

Related Keywords

Aeglea Biotherapeutics ,Aeglea Biotherapeutics Inc ,Pura Vida Investments ,Millennium Management ,Sphera Funds Management ,Nantahala Capital Management ,Get Rating ,Funds Management ,Capital Management ,Sigma Investments ,Nasdaq Agle ,Beagle ,Medical ,Initiated Coverage ,Stocknews Com ,